| Name | Title | Contact Details |
|---|
Medical Transportation Solutions is a State College, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Private Healthcare Systems Inc. is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cottage Glen Assisted Living is a Tooele, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Brightline is the first full-family behavioral health solution built specifically to care for kids, teens, and parents across a range of common family challenges. Launched at a time when 1 in 5 children has a behavioral health condition and up to 80% don't get the care they need, with increasing need exacerbated by the Covid-19 pandemic, Brightline is here to help families across the country thrive. With multidisciplinary care teams, personalized family system care, evidence-based care delivery, and extraordinary technology, Brightline is able to support families with whatever challenges they’re facing and ultimately help them thrive long-term. With Brightline, families can access support for a range of needs with our digital platform that includes resources and education for parents, interactive treatment exercises, and more; 1:1 coaching to support kids, teens, and parents with skill-building and guidance for dealing with tough stuff; behavior therapy, medication support, and speech therapy for a range of behavioral and developmental health needs. All right from home, right when families need it most. Join us to bring extraordinary care to families across the country!
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.